GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

Market Cap	440.12B
Revenue (ttm)	37.09B
Net Income (ttm)	9.55B
Shares Out	169.41M
EPS (ttm)	56.38
PE Ratio	46.08
Forward PE	40.67
Dividend	42.00 (1.62%)
Ex-Dividend Date	n/a

Volume	2,239
Average Volume	3,301
Open	2,615.00
Previous Close	2,623.95
Day's Range	2,561.00 - 2,615.95
52-Week Range	1,924.30 - 3,515.95
Beta	-0.01
RSI	55.70
Earnings Date	Feb 6, 2026

About BOM:500660

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease;...

• Industry: Pharmaceutical Preparations
• Founded: 1924
• Employees: 3,113
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500660

Financial Performance

In 2024, BOM:500660's revenue was 37.49 billion, an increase of 8.56% compared to the previous year's 34.54 billion. Earnings were 9.28 billion, an increase of 57.23%.